CME Group Now Rated a “Buy” at UBS (CME)
Futures exchange operator CME Group Inc. ( CME ) on Friday saw its rating and price target boosted by analysts at UBS.
The firm said it upgraded CME from "Neutral" to "Buy" with a $318 price target. That target suggests a 20% upside to the stock's Thursday closing price of $266.25.
Analysts at UBS noted the company has both cyclical and secular growth potential.
CME shares rose $3.75, or +1.4%, in premarket trading Friday.
The Bottom Line
Shares of CME Group ( CME ) have a 2.10% dividend yield, based on last night's closing stock price of $266.25. The stock has technical support in the $250-$260 price area. If the shares can firm up, we see overhead resistance around the $280 price level.
CME Group Inc. ( CME ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.